James Pavelka

743 citations
14 papers · 500 indexed · h-index 9
Topics
Endometrial and Cervical Cancer Treatments (4 papers)Ovarian cancer diagnosis and treatment (4 papers)BRCA gene mutations in cancer (2 papers)
Partner nations
United StatesJapan

In The Last Decade

James Pavelka

14 papers receiving 488 citations

Peers

James Pavelka
Comparison fields: 5 of 53
  • Obstetrics and Gynecology 242
  • Reproductive Medicine 231
  • Oncology 165
  • Molecular Biology 92
  • Cancer Research 67
Replace Erin A. Blake with:
Erin A. Blake United States
Ingolf Juhasz-Böess Germany
Bo Grønlund Denmark
Husheng Wang China
Christian Dannecker Germany
Bingying Xie China
E. De Muylder Belgium
Nanna Sarvilinna Finland
G. Vanderick Belgium
Bo Ma China
James Pavelka relative to Erin A. Blake United States Erin A. Blake's profile →
Citations per field
00.5×1.5×1.9×
Erin A. Blake · 1×
Citations per year

Countries citing papers authored by James Pavelka

Since Specialization
Citations

This map shows the geographic impact of James Pavelka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Pavelka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Pavelka more than expected).

Fields of papers citing papers by James Pavelka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Pavelka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Pavelka. The network helps show where James Pavelka may publish in the future.

Co-authorship network of co-authors of James Pavelka

This figure shows the co-authorship network connecting the top 25 collaborators of James Pavelka. A scholar is included among the top collaborators of James Pavelka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Pavelka. James Pavelka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 5
2 1
3 20
4 1
5 4
6 63
7 12
8 21
9 7
10 11
11 106
12 118
13 54
14 77

About James Pavelka

James Pavelka is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Genetics, having authored 14 papers that have together received 500 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Obstetrics and Gynecology (242 citations), Reproductive Medicine (231 citations) and Oncology (165 citations). James Pavelka has collaborated with scholars based in United States and Japan. Frequent co-authors include David E. Cohn, Inbar Ben‐Shachar, Jeffrey M. Fowler, Beth Y. Karlan, Larry J. Copeland, Nilsa C. Ramirez, Tom Manolitsas, Andrew J. Li, Ilana Cass and Ronald S. Leuchter. Their work appears in journals such as Journal of Clinical Oncology, Cancer and American Journal of Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026